{"title":"新冠肺炎后合并2型糖尿病患者临床1例","authors":"M. Y. Izmailova, K. M. Belova, T. L. Bogacheva","doi":"10.15829/2713-0177-2023-23","DOIUrl":null,"url":null,"abstract":"The presented review describes a clinical case of a comorbid patient type 2 diabetes mellitus (T2DM), the severity of whose disease was due to the presence of COVID-19 infection suffered on the eve of hospitalization, as well as the presence of concomitant diseases from the cardiovascular and nervous systems. In the aggregate of simultaneously occurring pathological processes, a patient with type 2 diabetes had a picture of uncontrolled hyperglycemia. The lifeline for the comorbid patient was orientation towards a more effective triple combined hypoglycemic therapy consisting of a type 2 sodium-glucose cotransporter 2 inhibitor, a medcine from the aGLP-1 group and metformin.","PeriodicalId":274852,"journal":{"name":"FOCUS. Endocrinology","volume":"101 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comorbid patient with type 2 diabetes in the postcovid period: clinical case\",\"authors\":\"M. Y. Izmailova, K. M. Belova, T. L. Bogacheva\",\"doi\":\"10.15829/2713-0177-2023-23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The presented review describes a clinical case of a comorbid patient type 2 diabetes mellitus (T2DM), the severity of whose disease was due to the presence of COVID-19 infection suffered on the eve of hospitalization, as well as the presence of concomitant diseases from the cardiovascular and nervous systems. In the aggregate of simultaneously occurring pathological processes, a patient with type 2 diabetes had a picture of uncontrolled hyperglycemia. The lifeline for the comorbid patient was orientation towards a more effective triple combined hypoglycemic therapy consisting of a type 2 sodium-glucose cotransporter 2 inhibitor, a medcine from the aGLP-1 group and metformin.\",\"PeriodicalId\":274852,\"journal\":{\"name\":\"FOCUS. Endocrinology\",\"volume\":\"101 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FOCUS. Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15829/2713-0177-2023-23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FOCUS. Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15829/2713-0177-2023-23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comorbid patient with type 2 diabetes in the postcovid period: clinical case
The presented review describes a clinical case of a comorbid patient type 2 diabetes mellitus (T2DM), the severity of whose disease was due to the presence of COVID-19 infection suffered on the eve of hospitalization, as well as the presence of concomitant diseases from the cardiovascular and nervous systems. In the aggregate of simultaneously occurring pathological processes, a patient with type 2 diabetes had a picture of uncontrolled hyperglycemia. The lifeline for the comorbid patient was orientation towards a more effective triple combined hypoglycemic therapy consisting of a type 2 sodium-glucose cotransporter 2 inhibitor, a medcine from the aGLP-1 group and metformin.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
